nodes	percent_of_prediction	percent_of_DWPC	metapath
Fondaparinux sodium—SERPINC1—Intrinsic Pathway—GP1BB—polycystic ovary syndrome	0.0973	0.187	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Formation of Fibrin Clot (Clotting Cascade)—GP1BB—polycystic ovary syndrome	0.0656	0.126	CbGpPWpGaD
Fondaparinux sodium—Distention—Metformin—polycystic ovary syndrome	0.0558	0.131	CcSEcCtD
Fondaparinux sodium—F10—Intrinsic Pathway—GP1BB—polycystic ovary syndrome	0.055	0.105	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Complement and Coagulation Cascades—CPB2—polycystic ovary syndrome	0.0419	0.0804	CbGpPWpGaD
Fondaparinux sodium—F10—Formation of Fibrin Clot (Clotting Cascade)—GP1BB—polycystic ovary syndrome	0.0371	0.0711	CbGpPWpGaD
Fondaparinux sodium—Abdominal bloating—Metformin—polycystic ovary syndrome	0.0276	0.0647	CcSEcCtD
Fondaparinux sodium—Epigastric discomfort—Metformin—polycystic ovary syndrome	0.025	0.0586	CcSEcCtD
Fondaparinux sodium—Acidosis—Metformin—polycystic ovary syndrome	0.0238	0.0556	CcSEcCtD
Fondaparinux sodium—F10—Complement and Coagulation Cascades—CPB2—polycystic ovary syndrome	0.0237	0.0454	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Glypican 1 network—NRG1—polycystic ovary syndrome	0.0214	0.0411	CbGpPWpGaD
Fondaparinux sodium—F10—Blood Clotting Cascade—PLAT—polycystic ovary syndrome	0.0193	0.037	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Complement and Coagulation Cascades—PLAT—polycystic ovary syndrome	0.0155	0.0298	CbGpPWpGaD
Fondaparinux sodium—F10—Beta2 integrin cell surface interactions—PLAT—polycystic ovary syndrome	0.0155	0.0297	CbGpPWpGaD
Fondaparinux sodium—Contusion—Metformin—polycystic ovary syndrome	0.0151	0.0353	CcSEcCtD
Fondaparinux sodium—Lightheadedness—Metformin—polycystic ovary syndrome	0.0118	0.0276	CcSEcCtD
Fondaparinux sodium—F10—endometrium—polycystic ovary syndrome	0.0106	0.203	CbGeAlD
Fondaparinux sodium—Renal impairment—Metformin—polycystic ovary syndrome	0.01	0.0235	CcSEcCtD
Fondaparinux sodium—SERPINC1—Glypican 1 network—VEGFA—polycystic ovary syndrome	0.00969	0.0186	CbGpPWpGaD
Fondaparinux sodium—F10—adipose tissue—polycystic ovary syndrome	0.00955	0.183	CbGeAlD
Fondaparinux sodium—Pain in extremity—Metformin—polycystic ovary syndrome	0.00955	0.0224	CcSEcCtD
Fondaparinux sodium—F10—Blood Clotting Cascade—SERPINE1—polycystic ovary syndrome	0.0091	0.0175	CbGpPWpGaD
Fondaparinux sodium—Dehydration—Metformin—polycystic ovary syndrome	0.00888	0.0208	CcSEcCtD
Fondaparinux sodium—F10—Complement and Coagulation Cascades—PLAT—polycystic ovary syndrome	0.00876	0.0168	CbGpPWpGaD
Fondaparinux sodium—F10—adrenal gland—polycystic ovary syndrome	0.00857	0.165	CbGeAlD
Fondaparinux sodium—F10—Post-translational protein modification—MANEA—polycystic ovary syndrome	0.00848	0.0163	CbGpPWpGaD
Fondaparinux sodium—Abdominal distension—Metformin—polycystic ovary syndrome	0.00831	0.0195	CcSEcCtD
Fondaparinux sodium—Sweating increased—Metformin—polycystic ovary syndrome	0.00804	0.0188	CcSEcCtD
Fondaparinux sodium—F10—female gonad—polycystic ovary syndrome	0.00799	0.153	CbGeAlD
Fondaparinux sodium—F10—vagina—polycystic ovary syndrome	0.00794	0.152	CbGeAlD
Fondaparinux sodium—SERPINC1—Hemostasis—GP1BB—polycystic ovary syndrome	0.00792	0.0152	CbGpPWpGaD
Fondaparinux sodium—F10—endocrine gland—polycystic ovary syndrome	0.00743	0.143	CbGeAlD
Fondaparinux sodium—Infestation—Metformin—polycystic ovary syndrome	0.00736	0.0172	CcSEcCtD
Fondaparinux sodium—Infestation NOS—Metformin—polycystic ovary syndrome	0.00736	0.0172	CcSEcCtD
Fondaparinux sodium—SERPINC1—Complement and Coagulation Cascades—SERPINE1—polycystic ovary syndrome	0.00732	0.014	CbGpPWpGaD
Fondaparinux sodium—F10—Post-translational protein modification—ADAMTS7—polycystic ovary syndrome	0.00703	0.0135	CbGpPWpGaD
Fondaparinux sodium—Hepatobiliary disease—Metformin—polycystic ovary syndrome	0.00696	0.0163	CcSEcCtD
Fondaparinux sodium—Hypoaesthesia—Metformin—polycystic ovary syndrome	0.00657	0.0154	CcSEcCtD
Fondaparinux sodium—Oedema peripheral—Metformin—polycystic ovary syndrome	0.00651	0.0152	CcSEcCtD
Fondaparinux sodium—Flushing—Metformin—polycystic ovary syndrome	0.00613	0.0144	CcSEcCtD
Fondaparinux sodium—Angiopathy—Metformin—polycystic ovary syndrome	0.00599	0.014	CcSEcCtD
Fondaparinux sodium—Immune system disorder—Metformin—polycystic ovary syndrome	0.00597	0.014	CcSEcCtD
Fondaparinux sodium—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.00595	0.0139	CcSEcCtD
Fondaparinux sodium—Malnutrition—Metformin—polycystic ovary syndrome	0.00575	0.0135	CcSEcCtD
Fondaparinux sodium—Flatulence—Metformin—polycystic ovary syndrome	0.00567	0.0133	CcSEcCtD
Fondaparinux sodium—Dysgeusia—Metformin—polycystic ovary syndrome	0.00563	0.0132	CcSEcCtD
Fondaparinux sodium—Vision blurred—Metformin—polycystic ovary syndrome	0.00542	0.0127	CcSEcCtD
Fondaparinux sodium—SERPINC1—Hemostasis—PDE3B—polycystic ovary syndrome	0.00531	0.0102	CbGpPWpGaD
Fondaparinux sodium—Syncope—Metformin—polycystic ovary syndrome	0.00516	0.0121	CcSEcCtD
Fondaparinux sodium—Palpitations—Metformin—polycystic ovary syndrome	0.00508	0.0119	CcSEcCtD
Fondaparinux sodium—Loss of consciousness—Metformin—polycystic ovary syndrome	0.00505	0.0118	CcSEcCtD
Fondaparinux sodium—Chest pain—Metformin—polycystic ovary syndrome	0.0049	0.0115	CcSEcCtD
Fondaparinux sodium—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.00486	0.0114	CcSEcCtD
Fondaparinux sodium—Oedema—Metformin—polycystic ovary syndrome	0.00469	0.011	CcSEcCtD
Fondaparinux sodium—Infection—Metformin—polycystic ovary syndrome	0.00466	0.0109	CcSEcCtD
Fondaparinux sodium—Shock—Metformin—polycystic ovary syndrome	0.00462	0.0108	CcSEcCtD
Fondaparinux sodium—Nervous system disorder—Metformin—polycystic ovary syndrome	0.0046	0.0108	CcSEcCtD
Fondaparinux sodium—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.00459	0.0108	CcSEcCtD
Fondaparinux sodium—Skin disorder—Metformin—polycystic ovary syndrome	0.00456	0.0107	CcSEcCtD
Fondaparinux sodium—SERPINC1—Hemostasis—RACGAP1—polycystic ovary syndrome	0.00455	0.00873	CbGpPWpGaD
Fondaparinux sodium—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.00454	0.0106	CcSEcCtD
Fondaparinux sodium—F10—Hemostasis—GP1BB—polycystic ovary syndrome	0.00447	0.00859	CbGpPWpGaD
Fondaparinux sodium—Anorexia—Metformin—polycystic ovary syndrome	0.00447	0.0105	CcSEcCtD
Fondaparinux sodium—F10—Metabolism of proteins—CGB5—polycystic ovary syndrome	0.0044	0.00845	CbGpPWpGaD
Fondaparinux sodium—Hypotension—Metformin—polycystic ovary syndrome	0.00439	0.0103	CcSEcCtD
Fondaparinux sodium—Paraesthesia—Metformin—polycystic ovary syndrome	0.00421	0.00987	CcSEcCtD
Fondaparinux sodium—Dyspnoea—Metformin—polycystic ovary syndrome	0.00418	0.0098	CcSEcCtD
Fondaparinux sodium—Somnolence—Metformin—polycystic ovary syndrome	0.00417	0.00977	CcSEcCtD
Fondaparinux sodium—F10—Complement and Coagulation Cascades—SERPINE1—polycystic ovary syndrome	0.00413	0.00794	CbGpPWpGaD
Fondaparinux sodium—Dyspepsia—Metformin—polycystic ovary syndrome	0.00413	0.00967	CcSEcCtD
Fondaparinux sodium—Decreased appetite—Metformin—polycystic ovary syndrome	0.00408	0.00955	CcSEcCtD
Fondaparinux sodium—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.00405	0.00949	CcSEcCtD
Fondaparinux sodium—Fatigue—Metformin—polycystic ovary syndrome	0.00405	0.00948	CcSEcCtD
Fondaparinux sodium—F10—Metabolism of proteins—MANEA—polycystic ovary syndrome	0.00403	0.00773	CbGpPWpGaD
Fondaparinux sodium—Constipation—Metformin—polycystic ovary syndrome	0.00401	0.0094	CcSEcCtD
Fondaparinux sodium—Feeling abnormal—Metformin—polycystic ovary syndrome	0.00387	0.00906	CcSEcCtD
Fondaparinux sodium—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.00384	0.00899	CcSEcCtD
Fondaparinux sodium—Urticaria—Metformin—polycystic ovary syndrome	0.00373	0.00873	CcSEcCtD
Fondaparinux sodium—Abdominal pain—Metformin—polycystic ovary syndrome	0.00371	0.00869	CcSEcCtD
Fondaparinux sodium—Asthenia—Metformin—polycystic ovary syndrome	0.00337	0.00789	CcSEcCtD
Fondaparinux sodium—F10—Metabolism of proteins—ADAMTS7—polycystic ovary syndrome	0.00334	0.0064	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—CPB2—polycystic ovary syndrome	0.00334	0.0064	CbGpPWpGaD
Fondaparinux sodium—Pruritus—Metformin—polycystic ovary syndrome	0.00332	0.00778	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Metformin—polycystic ovary syndrome	0.00321	0.00752	CcSEcCtD
Fondaparinux sodium—Dizziness—Metformin—polycystic ovary syndrome	0.0031	0.00727	CcSEcCtD
Fondaparinux sodium—F10—Hemostasis—PDE3B—polycystic ovary syndrome	0.003	0.00576	CbGpPWpGaD
Fondaparinux sodium—Vomiting—Metformin—polycystic ovary syndrome	0.00298	0.00699	CcSEcCtD
Fondaparinux sodium—Rash—Metformin—polycystic ovary syndrome	0.00296	0.00693	CcSEcCtD
Fondaparinux sodium—Dermatitis—Metformin—polycystic ovary syndrome	0.00296	0.00692	CcSEcCtD
Fondaparinux sodium—Headache—Metformin—polycystic ovary syndrome	0.00294	0.00689	CcSEcCtD
Fondaparinux sodium—Nausea—Metformin—polycystic ovary syndrome	0.00279	0.00653	CcSEcCtD
Fondaparinux sodium—SERPINC1—Hemostasis—PLAT—polycystic ovary syndrome	0.00278	0.00533	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—RACGAP1—polycystic ovary syndrome	0.00257	0.00493	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—INHBB—polycystic ovary syndrome	0.00253	0.00485	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—RPL37A—polycystic ovary syndrome	0.00227	0.00435	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—GNAS—polycystic ovary syndrome	0.00213	0.00409	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—LHB—polycystic ovary syndrome	0.00187	0.00359	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—IGFBP1—polycystic ovary syndrome	0.00167	0.00321	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—PLAT—polycystic ovary syndrome	0.00157	0.00301	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—LMNA—polycystic ovary syndrome	0.00139	0.00266	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—IGF1—polycystic ovary syndrome	0.00138	0.00265	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—AKT2—polycystic ovary syndrome	0.00138	0.00265	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—SERPINE1—polycystic ovary syndrome	0.00131	0.00252	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—GHRL—polycystic ovary syndrome	0.00123	0.00237	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—GNAS—polycystic ovary syndrome	0.0012	0.00231	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—ACE—polycystic ovary syndrome	0.0012	0.0023	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—TCF7L2—polycystic ovary syndrome	0.00115	0.0022	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—VEGFA—polycystic ovary syndrome	0.000902	0.00173	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—IGF1—polycystic ovary syndrome	0.00078	0.0015	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—AKT2—polycystic ovary syndrome	0.00078	0.0015	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—LEP—polycystic ovary syndrome	0.000743	0.00143	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—SERPINE1—polycystic ovary syndrome	0.000741	0.00142	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—POMC—polycystic ovary syndrome	0.000638	0.00122	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—INS—polycystic ovary syndrome	0.000635	0.00122	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—IGF1—polycystic ovary syndrome	0.000614	0.00118	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—VEGFA—polycystic ovary syndrome	0.00051	0.000978	CbGpPWpGaD
